Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response

NCT02823106 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study put on clinical hold by FDA. Sponsor decided to no pursue the study.

Conditions

Interventions

Sponsor

Justin Fraser